FY2025 · period end Dec '25 · from the 10-K filed Feb 11, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $5.14B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000915913-26-000087 | Jun 1, 2026 | Jun 5, 2026 | Jun 5, 2026 20:15 UTC | EDGAR |
| 8-K | 0000915913-26-000075 | May 5, 2026 | May 8, 2026 | May 8, 2026 20:40 UTC | EDGAR |
| 8-K | 0000915913-26-000070 | May 6, 2026 | May 6, 2026 | May 6, 2026 20:19 UTC | EDGAR |
| 10-Q | 0000915913-26-000072 | Mar 31, 2026 | May 6, 2026 | May 6, 2026 20:34 UTC | EDGAR |
| 8-K | 0000915913-26-000064 | Apr 13, 2026 | Apr 17, 2026 | Apr 17, 2026 20:36 UTC | EDGAR |
| 10-K/Aamend | 0000915913-26-000060 | Dec 31, 2025 | Mar 31, 2026 | Mar 31, 2026 20:19 UTC | EDGAR |
| 8-K | 0000915913-26-000057 | Mar 19, 2026 | Mar 25, 2026 | Mar 25, 2026 20:19 UTC | EDGAR |
| 8-K | 0000915913-26-000032 | Mar 2, 2026 | Mar 6, 2026 | Mar 6, 2026 21:10 UTC | EDGAR |
Direct links to SEC EDGAR. ALB has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Income (Loss) Attributable to Parent·3 months to Dec 2011
Major restatementwas$99.4M
Revised down in a 10-K. Any P/E built on the original was 118.3% too low.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q2 2012
Major restatementwas$43.3M
Revised up in a 10-Q.
Operating Income (Loss)·Q2 2012
Major restatementwas$52.4M
Revised up in a 10-Q.
Net Income (Loss) Attributable to Parent·Q2 2012
Major restatementwas$37.7M
Revised up in a 8-K. Any P/E built on the original was 24.7% too high.
Gross Profit·Q3 2015
Major restatementwas$312.2M
Revised down in a 10-K.
Gross Profit·Q2 2015
Major restatementwas$300.6M
Revised down in a 10-K.
ALB is not the only one.
See every restatement we've found across the market — or get an alert the next time ALB revises a number.
Restatements are detected by comparing every vintage of a fact across all of ALBEMARLE CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ALB's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling ALBEMARLE CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ALB yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ALB and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $9.62B |
| $7.32B |
| $3.33B |
| Gross Profit | $0.67B | $0.06B | $1.19B | $3.07B | $1.00B |
|---|
| Operating Income | negative: -$0.37B | negative: -$1.78B | $0.25B | $2.47B | $0.80B |
|---|
| Net Income | negative: -$0.51B | negative: -$1.18B | $1.57B | $2.69B | $0.12B |
|---|
| EPS (Diluted) | negative: -$5.76 | negative: -$11.20 | $13.36 | $22.84 | $1.06 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $16.37B | $16.61B | $18.27B | $15.46B | $10.97B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $9.78B | $10.20B | $9.67B | $8.19B | $5.81B |
| Cash & Equivalents | $1.62B | $1.19B | $0.89B | $1.50B | $0.44B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.28B | $0.69B | $1.33B | $1.91B | $0.34B |
| Capital Expenditures | $0.59B | $1.68B | $2.15B | $1.26B | $0.95B |
| Free Cash Flow | $0.69B | negative: -$0.99B | negative: -$0.83B | $0.65B | negative: -$0.61B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 13.0% | 1.2% | 12.3% | 42.0% | 30.0% |
| Operating Margin | negative: -0.1% | negative: -0.3% | 0.0% | 0.3% | 0.2% |
| Net Margin | negative: -0.1% | negative: -0.2% | 0.2% | 0.4% | 0.0% |
| Return on Equity | negative: -5.1% | negative: -11.9% | 17.6% | 38.4% | 2.4% |
| Return on Assets | negative: -3.1% | negative: -6.8% | 9.3% | 20.4% | 1.2% |
| Debt / Equity | 0.33× | 0.44× | 0.50× | 0.39× | 0.48× |
